Results 31 to 40 of about 1,620,123 (298)

Targeted Delivery of Auristatin-Modified Toxins to Pancreatic Cancer Using Aptamers

open access: yesMolecular Therapy: Nucleic Acids, 2018
Pancreatic cancer is one of the most lethal malignancies. Treatment with the first-line agent, gemcitabine, is often unsuccessful because it, like other traditional chemotherapeutic agents, is non-specific, resulting in off-target effects that ...
Christina Kratschmer, Matthew Levy
doaj   +1 more source

Cancer Drug Delivery Systems Using Bacterial Toxin Translocation Mechanisms

open access: yesBioengineering, 2023
Recent advances in targeted cancer therapy hold great promise for both research and clinical applications and push the boundaries in finding new treatments for various currently incurable cancers.
Linxiang Yin, Hatim Thaker
doaj   +1 more source

Release of vasopressin from isolated permeabilized neurosecretory nerve terminals is blocked by the light chain of botulinum A toxin [PDF]

open access: yes, 1990
The intracellular action on exocytosis of botulinim A toxin and constituent chains was studied using permeabilized isolated nerve endings from the rat neural lobe. The release of the neuropeptide vasopressin was measured by radioimmunoassay.
Weller, U.   +4 more
core   +1 more source

Characterizing RecA-Independent Induction of Shiga toxin2-encoding Phages by EDTA Treatment [PDF]

open access: yes, 2012
The bacteriophage life cycle has an important role in Shiga toxin (Stx) expression. The induction of Shiga toxin-encoding phages (Stx phages) increases toxin production as a result of replication of the phage genome, and phage lysis of the host cell also
Muniesa Maite   +8 more
core   +3 more sources

Hosts and Heterologous Expression Strategies of Recombinant Toxins for Therapeutic Purposes

open access: yesToxins, 2023
The production of therapeutic recombinant toxins requires careful host cell selection. Bacteria, yeast, and mammalian cells are common choices, but no universal solution exists.
Luana di Leandro   +3 more
doaj   +1 more source

Venom and Toxin as Targeted Therapy [PDF]

open access: yes, 2019
Targeted therapy has developed significantly in the last one and half decades, prescribing specific medications for treatment of particular diseases, such as cancer, diabetes, and heart disease.
Kwok, Hang Fai (Henry)
core   +1 more source

Immunotoxins: Targeted Toxin Delivery for Cancer Therapy

open access: yesPharmaceutical Fronts, 2019
Immunotoxins are proteins that consist of a protein toxin conjugated to a specific targeting moiety. The targeting moiety is usually an antibody or ligand, such as monoclonal antibody, antibody fragment, a cytokine, or a growth factor. The toxins usually
Xin Mei   +3 more
doaj   +1 more source

Mutagenic Deimmunization of Diphtheria Toxin for Use in Biologic Drug Development

open access: yesToxins, 2015
Background: Targeted toxins require multiple treatments and therefore must be deimmunized. We report a method of protein deimmunization based on the point mutation of highly hydrophilic R, K, D, E, and Q amino acids on the molecular surface of truncated ...
Joerg U. Schmohl   +3 more
doaj   +1 more source

Bacterial protein toxins and lipids: role in toxin targeting and activity [PDF]

open access: yesBiology of the Cell, 2006
All bacterial toxins, which globally are hydrophilic proteins, interact first with their target cells by recognizing a surface receptor, which is either a lipid or a lipid derivative, or another compound but in a lipid environment. Intracellular active toxins follow various trafficking pathways, the sorting of which is greatly dependent on the nature ...
Blandine, Geny, Michel R, Popoff
openaire   +2 more sources

Syntaxin 16 and syntaxin 5 are required for efficient retrograde transport of several exogenous and endogenous cargo proteins [PDF]

open access: yes, 2007
Retrograde transport allows proteins and lipids to leave the endocytic pathway to reach other intracellular compartments, such as trans-Golgi network (TGN)/Golgi membranes, the endoplasmic reticulum and, in some instances, the cytosol. Here, we have used
Falguières, Thomas   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy